Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adeel A Butt

Showing results (21-30 of 254) with videos related to

Pageof 26
Sort By:
AIDS Research and Human Retroviruses|February 23, 2011
A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veteransAdeel A Butt, Kathleen McGinnis, Melissa Skanderson, et al.
Journal of Hepatology|March 7, 2006
Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysisAdeel A Butt, Robert Evans, Melissa Skanderson, et al.
Health Science Reports|June 25, 2024
The impact of COVID-19 on the clinical course and outcome of patients with cirrhosis: An observational studyObaid S Shaikh, Peng Yan, Shari Rogal, et al.
ISRN Gastroenterology|July 10, 2014
Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus CoinfectionSebhat Erqou, Arpan Mohanty, Pashtoon Murtaza Kasi, et al.
Eclinicalmedicine|September 3, 2021
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national populationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2009
Hepatitis C treatment completion rates in routine clinical careAdeel A Butt, Kathleen A McGinnis, Melissa Skanderson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2021
Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infectionAdeel A Butt, Peng Yan, Rashid A Chotani, et al.
The Journal of Infectious Diseases|October 8, 2024
COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and VaccinatedAdeel A Butt, Peng Yan, Abdul-Badi Abou-Samra, et al.
Hepatology (Baltimore, Md.)|February 19, 2016
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVESTracey G Simon, Hector Bonilla, Peng Yan, et al.
The New England Journal of Medicine|February 9, 2022
Effectiveness of Homologous or Heterologous Covid-19 Boosters in VeteransFlorian B Mayr, Victor B Talisa, Obaid Shaikh, et al.
Pageof 26

Showing results (21-30 of 254) with videos related to

Sort By:
Pageof 26
AIDS Research and Human Retroviruses|February 23, 2011
A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veteransAdeel A Butt, Kathleen McGinnis, Melissa Skanderson, et al.
Journal of Hepatology|March 7, 2006
Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysisAdeel A Butt, Robert Evans, Melissa Skanderson, et al.
Health Science Reports|June 25, 2024
The impact of COVID-19 on the clinical course and outcome of patients with cirrhosis: An observational studyObaid S Shaikh, Peng Yan, Shari Rogal, et al.
ISRN Gastroenterology|July 10, 2014
Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus CoinfectionSebhat Erqou, Arpan Mohanty, Pashtoon Murtaza Kasi, et al.
Eclinicalmedicine|September 3, 2021
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national populationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2009
Hepatitis C treatment completion rates in routine clinical careAdeel A Butt, Kathleen A McGinnis, Melissa Skanderson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2021
Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infectionAdeel A Butt, Peng Yan, Rashid A Chotani, et al.
The Journal of Infectious Diseases|October 8, 2024
COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and VaccinatedAdeel A Butt, Peng Yan, Abdul-Badi Abou-Samra, et al.
Hepatology (Baltimore, Md.)|February 19, 2016
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVESTracey G Simon, Hector Bonilla, Peng Yan, et al.
The New England Journal of Medicine|February 9, 2022
Effectiveness of Homologous or Heterologous Covid-19 Boosters in VeteransFlorian B Mayr, Victor B Talisa, Obaid Shaikh, et al.
Pageof 26